RFA plus lyso-thermosensitive liposomal doxorubicin: in search of the optimal approach to cure intermediate-size hepatocellular carcinoma

When heated during a radiofrequency ablation (RFA) procedure to ≥40°C, lyso-thermosensitive liposomal doxorubicin (LTLD) produces high drug concentration in the surrounding margins of the ablation zone. The hypothesis that the RFA + LTLD combination can effectively treat hepatocellular carcinoma (HC...

Full description

Saved in:
Bibliographic Details
Published in:Hepat Oncol
Main Authors: Lencioni, Riccardo, Cioni, Dania
Format: Artigo
Language:Inglês
Published: Future Medicine Ltd 2016
Subjects:
Drug Evaluation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6095431/
https://ncbi.nlm.nih.gov/pubmed/30191041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep-2016-0005
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items